RHBG Expression Is Correlated With ccRCC Proliferation and Immune Infiltration

Ying Song¹ and Haiming Yu^1,

¹Department of Pharmacy, Shengli Oilfield Central Hospital, Dongying, Shandong, 257034, China

Cite this paper:
Ying Song and Haiming Yu. RHBG Expression Is Correlated With ccRCC Proliferation and Immune Infiltration. Journal of Food and Nutrition Research. 2024; 12(3):115-124. doi: 10.12691/jfnr-12-3-2

Abstract

Clear cell renal cell carcinoma (ccRCC) is one of the pathological types of renal cell carcinoma with poor prognosis, which poses a serious threat to human life. Therefore, there is a need to develop appropriate tumor markers to predict the development, treatment, and prognosis of ccRCC. As a member of a new protein family involved in ammonia transport in the mammalian kidney, RHBG plays an important role in the kidney. Therefore, the relationship between RHBG and clinical characteristics, prognostic risk, overall survival and immune infiltration in patients with clear cell renal cell carcinoma was explored by bioinformatics. The Cancer Genome Atlas (TCGA) database was used to evaluate the correlation between RHBG and ccRCC. The results showed that the expression of RHBG in renal cancer tissues was lower than that in normal tissues (P<0.001); ROC curve showed that RHBG had a high diagnostic value (AUC=0.957). The low expression of RHBG is associated with the immune status of renal clear cell carcinoma. These data suggest that RHBG is a viable potential biomarker for ccRCC with great potential for future clinical application and translation.

Keywords:
TCGA ccRCC RHBG

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	B. Ma, L. Qin, Z. Sun, J. Wang, L.J. Tran, J. Zhang, F. Ye, Y. Liu, M. Chen, The single-cell evolution trajectory presented different hypoxia heterogeneity to reveal the carcinogenesis of genes in clear cell renal cell carcinoma: Based on multiple omics and real experimental verification, Environmental Toxicology, 39 (2024) 869-881.
[2]	Z. Ren, Y. Niu, B. Fan, A. Zhang, Upregulation of homeobox D10 expression suppresses invasion and migration of clear cell renal cell carcinoma through targeting of E-cadherin, Molecular Biology Reports, 49 (2022) 1837-1846.
[3]	J.-x. Chen, D. Xu, J.-w. Cao, L. Zuo, Z.-t. Han, Y.-j. Tian, C.-m. Chu, W. Zhou, X.-w. Pan, X.-g. Cui, TRIM47 promotes malignant progression of renal cell carcinoma by degrading P53 through ubiquitination, Cancer Cell International, 21 (2021) 129.
[4]	M. Véron, S. Chevret, J.-J. Grob, M. Beylot-Barry, P. Saiag, A. Fléchon, B. You, E. Maubec, T. Jouary, E. Toulemonde, P. Jamme, L. Gambotti, A. Lamrani-Ghaouti, A. Dupuy, C. Lebbe, N.B. Seguin, N. Houede, M.-T. Leccia, F. Le Du, M. de Pontville, C. Gaudy-Marquestre, B. Guillot, C. Simon, A. Marabelle, L. Mortier, Safety and efficacy of nivolumab, an anti-PD1 immunotherapy, in patients with advanced basal cell carcinoma, after failure or intolerance to sonic Hedgehog inhibitors: UNICANCER AcSé NIVOLUMAB trial, European Journal of Cancer, 177 (2022) 103-111.
[5]	B. René, B. Jacobus Adrianus, Optimisation of chemotherapy in the era of immunotherapy, European Respiratory Journal, 52 (2018) 1801698.
[6]	E. Kadife, E. Chan, R. Luwor, G. Kannourakis, J. Findlay, N. Ahmed, Paclitaxel-Induced Src Activation Is Inhibited by Dasatinib Treatment, Independently of Cancer Stem Cell Properties, in a Mouse Model of Ovarian Cancer, Cancers, 2019.
[7]	M. Ambalavanan, J.I. Geller, Treatment of advanced pediatric renal cell carcinoma, Pediatric Blood & Cancer, 66 (2019) e27766.
[8]	M. Li, A. Shi, W. Kong, J. Zhang, Y. Chen, J. Huang, Y. Huang, Transitional cell carcinoma with extension of the renal vein and IVC tumor thrombus: report of three cases and literature review, World Journal of Surgical Oncology, 14 (2016) 309.
[9]	T. Guo, T. Wang, J. Zhang, S. Chen, X. Wang, HIF1A predicts the efficacy of anti-PD-1 therapy in advanced clear cell renal cell carcinoma, Translational Oncology, 26 (2022) 101554.
[10]	W.G. Breen, M.J. Blanchard, A.N. Rao, D.J. Daniels, J.C. Buckner, N.N.I. Laack, Optimal radiotherapy target volumes in intracranial nongerminomatous germ cell tumors: Long-term institutional experience with chemotherapy, surgery, and dose- and field-adapted radiotherapy, Pediatric Blood & Cancer, 64 (2017) e26637.
[11]	Y. Zhao, W. Lian, B. Xing, M. Feng, X. Liu, R. Wang, W. Zhou, Diagnosis, Therapy, and Therapeutic Effects in Cases of Pituitary Metastasis, World Neurosurgery, 117 (2018) 122-128.
[12]	C. Li, Y. Zhang, Q. Xia, B. Hao, Y. Hong, L. Yue, T. Zheng, M. Li, L. Fan, Multi-omics analysis revealed the mitochondrial-targeted drug combination to suppress the development of lung cancer, Journal of Cancer Research and Clinical Oncology, 149 (2023) 17159-17174.
[13]	J. Zhou, E.-J. Yun, W. Chen, Y. Ding, K. Wu, B. Wang, C. Ding, E. Hernandez, J. Santoyo, R.-C. Pong, H. Chen, D. He, J. Zhou, J.-T. Hsieh, Targeting 3-phosphoinositide-dependent protein kinase 1 associated with drug-resistant renal cell carcinoma using new oridonin analogs, Cell Death & Disease, 8 (2017) e2701-e2701.
[14]	X. Zhu, C. Fan, Z. Xiong, M. Chen, Z. Li, T. Tao, X. Liu, Development and application of oncolytic viruses as the nemesis of tumor cells, Frontiers in Microbiology, 14 (2023).
[15]	H. Han, X. Feng, Y. Guo, M. Cheng, Z. Cui, S. Guo, W. Zhou, Identification of potential target genes of breast cancer in response to Chidamide treatment, Frontiers in Molecular Biosciences, 9 (2022).
[16]	L. Zhang, M. Liu, Z. Zhang, D. Chen, G. Chen, M. Liu, Machine learning based identification of hub genes in renal clear cell carcinoma using multi-omics data, Methods, 207 (2022) 110-117.
[17]	X. Wang, B. Hao, C. Xu, X. Zhao, C. Liu, X. Chu, Y. Lv, Y. Zhao, S. Zhang, P. Wang, Y. Wang, Involvement of erbB4 and tumor marker genes in renal carcinoma regulatory network, Saudi Journal of Biological Sciences, 24 (2017) 1787-1791.
[18]	F. Quentin, D. Eladari, L. Cheval, C. Lopez, D. Goossens, Y. Colin, J.-P. Cartron, M. Paillard, R. Chambrey, RhBG and RhCG, the Putative Ammonia Transporters, Are Expressed in the Same Cells in the Distal Nephron, Journal of the American Society of Nephrology, 14 (2003).
[19]	D. Eladari, L. Cheval, F. Quentin, O. Bertrand, I. Mouro, B. Cherif-Zahar, J.-P. Cartron, M. Paillard, A. Doucet, R. Chambrey, Expression of RhCG, a New Putative NH3/NH4+ Transporter, along the Rat Nephron, Journal of the American Society of Nephrology, 13 (2002).
[20]	C.-H. Huang, P.Z. Liu, New Insights into the Rh Superfamily of Genes and Proteins in Erythroid Cells and Nonerythroid Tissues, Blood Cells, Molecules, and Diseases, 27 (2001) 90-101.
[21]	C.L. Van Kim, Y. Colin, J.-P. Cartron, Rh proteins: Key structural and functional components of the red cell membrane, Blood Reviews, 20 (2006) 93-110.
[22]	A.M. Clifford, Lessons in waste management: Deciphering the dual role of Crustacean Rh1 protein in ammonia and CO2 excretion, Acta Physiologica, 240 (2024) e14079.
[23]	F. Quentin, D. Eladari, L. Cheval, C. Lopez, D. Goossens, Y. Colin, J.P. Cartron, M. Paillard, R. Chambrey, RhBG and RhCG, the putative ammonia transporters, are expressed in the same cells in the distal nephron, J Am Soc Nephrol, 14 (2003) 545-554.
[24]	N.L. Nakhoul, S.M. Abdulnour-Nakhoul, E.L. Boulpaep, E. Rabon, E. Schmidt, L.L. Hamm, Substrate specificity of Rhbg: ammonium and methyl ammonium transport, Am J Physiol Cell Physiol, 299 (2010) C695-705.
[25]	O. Hes, E.M. Compérat, N. Rioux-Leclercq, Clear cell papillary renal cell carcinoma, renal angiomyoadenomatous tumor, and renal cell carcinoma with leiomyomatous stroma relationship of 3 types of renal tumors: a review, Annals of Diagnostic Pathology, 21 (2016) 59-64.
[26]	D. Lv, H. Zhou, F. Cui, J. Wen, W. Shuang, Characterization of renal artery variation in patients with clear cell renal cell carcinoma and the predictive value of accessory renal artery in pathological grading of renal cell carcinoma: a retrospective and observational study, BMC Cancer, 23 (2023) 274.
[27]	J.W. Verlander, R.T. Miller, A.E. Frank, I.E. Royaux, Y.H. Kim, I.D. Weiner, Localization of the ammonium transporter proteins RhBG and RhCG in mouse kidney, Am J Physiol Renal Physiol, 284 (2003) F323-337.
[28]	N.L. Nakhoul, S.M. Abdulnour-Nakhoul, E. Schmidt, R. Doetjes, E. Rabon, L.L. Hamm, pH sensitivity of ammonium transport by Rhbg, Am J Physiol Cell Physiol, 299 (2010) C1386-1397.
[29]	R.R. Geyer, M.D. Parker, A.M. Toye, W.F. Boron, R. Musa-Aziz, Relative CO₂/NH₃ permeabilities of human RhAG, RhBG and RhCG, J Membr Biol, 246 (2013) 915-926.
[30]	D.O. Mak, B. Dang, I.D. Weiner, J.K. Foskett, C.M. Westhoff, Characterization of ammonia transport by the kidney Rh glycoproteins RhBG and RhCG, Am J Physiol Renal Physiol, 290 (2006) F297-305.
[31]	C. Lopez, S. Métral, D. Eladari, S. Drevensek, P. Gane, R. Chambrey, V. Bennett, J.P. Cartron, C. Le Van Kim, Y. Colin, The ammonium transporter RhBG: requirement of a tyrosine-based signal and ankyrin-G for basolateral targeting and membrane anchorage in polarized kidney epithelial cells, J Biol Chem, 280 (2005) 8221-8228.
[32]	H.W. Lee, J.W. Verlander, M.E. Handlogten, K.H. Han, P.S. Cooke, I.D. Weiner, Expression of the rhesus glycoproteins, ammonia transporter family members, RHCG and RHBG in male reproductive organs, Reproduction, 146 (2013) 283-296.
[33]	A.C. Brown, D. Hallouane, W.J. Mawby, F.E. Karet, M.A. Saleem, A.J. Howie, A.M. Toye, RhCG is the major putative ammonia transporter expressed in the human kidney, and RhBG is not expressed at detectable levels, Am J Physiol Renal Physiol, 296 (2009) F1279-1290.